{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T21:36:01Z","timestamp":1793914561763,"version":"4.8.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,30]],"date-time":"2019-12-30T00:00:00Z","timestamp":1577664000000},"content-version":"vor","delay-in-days":29,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>The majority of in vitro studies of medically relevant biofilms involve the development of biofilm on an inanimate solid surface. However, infection in vivo consists of biofilm growth on, or suspended within, the semi-solid matrix of the tissue, whereby current models do not effectively simulate the nature of the in vivo environment. This paper describes development of an in vitro method for culturing wound associated microorganisms in a system that combines a semi-solid collagen gel matrix with continuous flow of simulated wound fluid. This enables culture of wound associated reproducible steady state biofilms under conditions that more closely simulate the dynamic wound environment. To demonstrate the use of this model the antimicrobial kinetics of ceftazidime, against both mature and developing <jats:italic>Pseudomonas aeruginosa<\/jats:italic> biofilms, was assessed. In addition, we have shown the potential application of this model system for investigating microbial metabolomics by employing selected ion flow tube mass spectrometry (SIFT-MS) to monitor ammonia and hydrogen cyanide production by <jats:italic>Pseudomonas aeruginosa<\/jats:italic> biofilms in real-time.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>The collagen wound biofilm model facilitates growth of steady-state reproducible <jats:italic>Pseudomonas aeruginosa<\/jats:italic> biofilms under wound like conditions. A maximum biofilm density of 10<jats:sup>10<\/jats:sup>\u2009cfu slide<jats:sup>\u2212\u20091<\/jats:sup> was achieved by 30\u2009h of continuous culture and maintained throughout the remainder of the experiment. Treatment with ceftazidime at a clinically relevant dose resulted in a 1.2\u20131.6 log reduction in biofilm density at 72\u2009h compared to untreated controls. Treatment resulted in loss of complex biofilm architecture and morphological changes to bacterial cells, visualised using confocal microscopy. When monitoring the biofilms using SIFT-MS, ammonia and hydrogen cyanide levels peaked at 12\u2009h at 2273\u2009ppb (\u00b1826.4) and 138\u2009ppb (\u00b149.1) respectively and were detectable throughout experimentation.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>The collagen wound biofilm model has been developed to facilitate growth of reproducible biofilms under wound-like conditions. We have successfully used this method to: (1) evaluate antimicrobial efficacy and kinetics, clearly demonstrating the development of antimicrobial tolerance in biofilm cultures; (2) characterise volatile metabolite production by <jats:italic>P. aeruginosa<\/jats:italic> biofilms, demonstrating the potential use of this method in metabolomics studies.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12866-019-1682-5","type":"journal-article","created":{"date-parts":[[2019,12,30]],"date-time":"2019-12-30T22:02:51Z","timestamp":1577743371000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["An in vitro collagen perfusion wound biofilm model; with applications for antimicrobial studies and microbial metabolomics"],"prefix":"10.1186","volume":"19","author":[{"given":"Elisabeth A.","family":"Slade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin M. S.","family":"Thorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7002-1320","authenticated-orcid":false,"given":"Darren M.","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,30]]},"reference":[{"key":"1682_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00203-015-1148-6","volume":"198","author":"P Gupta","year":"2016","unstructured":"Gupta P, Sarkar S, Das B, Bhattacharjee S, Tribedi P. Biofilm, pathogenesis and prevention\u2014a journey to break the wall: a review. Arch Microbiol. 2016;198:1\u201315. https:\/\/doi.org\/10.1007\/s00203-015-1148-6.","journal-title":"Arch Microbiol"},{"key":"1682_CR2","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.cmi.2014.10.024","volume":"21","author":"N H\u00f8iby","year":"2015","unstructured":"H\u00f8iby N, Bjarnsholt T, Moser C, Bassi GL, Coenye T, Donelli G, et al. ESCMID guideline for the diagnosis and treatment of biofilm infections 2014. Clin Microbiol Infect. 2015;21:S1\u201325. https:\/\/doi.org\/10.1016\/j.cmi.2014.10.024.","journal-title":"Clin Microbiol Infect"},{"key":"1682_CR3","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1128\/JB.188.4.1211-1217.2006","volume":"188","author":"S Furukawa","year":"2006","unstructured":"Furukawa S, Kuchma SL, O\u2019Toole GA. Keeping their options open: acute versus persistent infections. J Bacteriol. 2006;188:1211\u20137. https:\/\/doi.org\/10.1128\/JB.188.4.1211-1217.2006.","journal-title":"J Bacteriol"},{"key":"1682_CR4","doi-asserted-by":"publisher","first-page":"570","DOI":"10.12968\/jowc.2014.23.11.570","volume":"23","author":"R Cooper","year":"2014","unstructured":"Cooper R, Bjarnsholt T, Alhede M. Biofilms in wounds: a review of present knowledge. J Wound Care. 2014;23:570\u201382. https:\/\/doi.org\/10.12968\/jowc.2014.23.11.570.","journal-title":"J Wound Care"},{"key":"1682_CR5","doi-asserted-by":"publisher","first-page":"4329","DOI":"10.4049\/JIMMUNOL.171.8.4329","volume":"171","author":"AJ Jesaitis","year":"2003","unstructured":"Jesaitis AJ, Franklin MJ, Berglund D, Sasaki M, Lord CI, Bleazard JB, et al. Compromised host defense on Pseudomonas aeruginosa biofilms: characterization of neutrophil and biofilm interactions. J Immunol. 2003;171:4329\u201339. https:\/\/doi.org\/10.4049\/JIMMUNOL.171.8.4329.","journal-title":"J Immunol"},{"key":"1682_CR6","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/femsre\/fux010","volume":"41","author":"CW Hall","year":"2017","unstructured":"Hall CW, Mah T-F. Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria. FEMS Microbiol Rev. 2017;41:276\u2013301. https:\/\/doi.org\/10.1093\/femsre\/fux010.","journal-title":"FEMS Microbiol Rev"},{"key":"1682_CR7","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/nrd1008","volume":"2","author":"D Davies","year":"2003","unstructured":"Davies D. Understanding biofilm resistance to antibacterial agents. Nat Rev Drug Discov. 2003;2:114\u201322. https:\/\/doi.org\/10.1038\/nrd1008.","journal-title":"Nat Rev Drug Discov"},{"key":"1682_CR8","doi-asserted-by":"publisher","first-page":"e27943","DOI":"10.1371\/journal.pone.0027943","volume":"6","author":"M Alhede","year":"2011","unstructured":"Alhede M, Kragh KN, Qvortrup K, Allesen-Holm M, van Gennip M, Christensen LD, et al. Phenotypes of non-attached Pseudomonas aeruginosa aggregates resemble surface attached biofilm. PLoS One. 2011;6:e27943. https:\/\/doi.org\/10.1371\/journal.pone.0027943.","journal-title":"PLoS One"},{"key":"1682_CR9","doi-asserted-by":"publisher","first-page":"20","DOI":"10.12968\/jowc.2017.26.1.20","volume":"26","author":"M Malone","year":"2017","unstructured":"Malone M, Bjarnsholt T, McBain AJ, James GA, Stoodley P, Leaper D, et al. The prevalence of biofilms in chronic wounds: a systematic review and meta-analysis of published data. J Wound Care. 2017;26:20\u20135. https:\/\/doi.org\/10.12968\/jowc.2017.26.1.20.","journal-title":"J Wound Care"},{"key":"1682_CR10","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1128\/JCM.00501-08","volume":"46","author":"K Kirketerp-Moller","year":"2008","unstructured":"Kirketerp-Moller K, Jensen PO, Fazli M, Madsen KG, Pedersen J, Moser C, et al. Distribution, organization, and ecology of Bacteria in chronic wounds. J Clin Microbiol. 2008;46:2717\u201322. https:\/\/doi.org\/10.1128\/JCM.00501-08.","journal-title":"J Clin Microbiol"},{"key":"1682_CR11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1524-475X.2007.00303.x","volume":"16","author":"SC Davis","year":"2008","unstructured":"Davis SC, Ricotti C, Cazzaniga A, Welsh E, Eaglstein WH, Mertz PM. Microscopic and physiologic evidence for biofilm-associated wound colonization in vivo. Wound Repair Regen. 2008;16:23\u20139. https:\/\/doi.org\/10.1111\/j.1524-475X.2007.00303.x.","journal-title":"Wound Repair Regen"},{"key":"1682_CR12","doi-asserted-by":"publisher","first-page":"4084","DOI":"10.1128\/JCM.01395-09","volume":"47","author":"M Fazli","year":"2009","unstructured":"Fazli M, Bjarnsholt T, Kirketerp-Moller K, Jorgensen B, Andersen AS, Krogfelt KA, et al. Nonrandom distribution of Pseudomonas aeruginosa and Staphylococcus aureus in chronic wounds. J Clin Microbiol. 2009;47:4084\u20139. https:\/\/doi.org\/10.1128\/JCM.01395-09.","journal-title":"J Clin Microbiol"},{"key":"1682_CR13","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1111\/iwj.12777","volume":"14","author":"K Johani","year":"2017","unstructured":"Johani K, Malone M, Jensen S, Gosbell I, Dickson H, Hu H, et al. Microscopy visualisation confirms multi-species biofilms are ubiquitous in diabetic foot ulcers. Int Wound J. 2017;14:1160\u20139. https:\/\/doi.org\/10.1111\/iwj.12777.","journal-title":"Int Wound J"},{"key":"1682_CR14","doi-asserted-by":"publisher","first-page":"3715","DOI":"10.1128\/IAI.00586-07","volume":"75","author":"JA Schaber","year":"2007","unstructured":"Schaber JA, Triffo WJ, Suh SJ, Oliver JW, Hastert MC, Griswold JA, et al. Pseudomonas aeruginosa forms biofilms in acute infection independent of cell-to-cell signaling \u2020. Infect Immun. 2007;75:3715\u201321. https:\/\/doi.org\/10.1128\/IAI.00586-07.","journal-title":"Infect Immun"},{"key":"1682_CR15","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1128\/AAC.01944-13","volume":"58","author":"MG Thompson","year":"2014","unstructured":"Thompson MG, Black CC, Pavlicek RL, Honnold CL, Wise MC, Alamneh YA, et al. Validation of a novel murine wound model of Acinetobacter baumannii infection. Antimicrob Agents Chemother. 2014;58:1332\u201342. https:\/\/doi.org\/10.1128\/AAC.01944-13.","journal-title":"Antimicrob Agents Chemother"},{"key":"1682_CR16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.mimet.2010.08.018","volume":"83","author":"T Coenye","year":"2010","unstructured":"Coenye T, Nelis HJ. In vitro and in vivo model systems to study microbial biofilm formation. J Microbiol Methods. 2010;83:89\u2013105. https:\/\/doi.org\/10.1016\/j.mimet.2010.08.018.","journal-title":"J Microbiol Methods"},{"key":"1682_CR17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1524-475X.2007.00321.x","volume":"16","author":"GA James","year":"2008","unstructured":"James GA. Swogger E, Wolcott R, Pulcini E deLancey, Secor P, Sestrich J, et al. biofilms in chronic wounds. Wound Repair Regen. 2008;16:37\u201344. https:\/\/doi.org\/10.1111\/j.1524-475X.2007.00321.x.","journal-title":"Wound Repair Regen"},{"key":"1682_CR18","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/j.1600-0463.2009.02580.x","volume":"118","author":"M Werth\u00e9n","year":"2010","unstructured":"Werth\u00e9n M, Henriksson L, Jensen P\u00d8, Sternberg C, Givskov M, Bjarnsholt T. An in vitro model of bacterial infections in wounds and other soft tissues. APMIS. 2010;118:156\u201364. https:\/\/doi.org\/10.1111\/j.1600-0463.2009.02580.x.","journal-title":"APMIS."},{"key":"1682_CR19","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1128\/AAC.00045-11","volume":"55","author":"G Brackman","year":"2011","unstructured":"Brackman G, Cos P, Maes L, Nelis HJ, Coenye T. Quorum sensing inhibitors increase the susceptibility of bacterial biofilms to antibiotics in vitro and in vivo. Antimicrob Agents Chemother. 2011;55:2655\u201361.","journal-title":"Antimicrob Agents Chemother"},{"key":"1682_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/768136","volume":"2014","author":"B Hakonen","year":"2014","unstructured":"Hakonen B, L\u00f6nnberg LK, Lark\u00f6 E, Blom K. A novel qualitative and quantitative biofilm assay based on 3D soft tissue. Int J Biomater. 2014;2014:1\u20135. https:\/\/doi.org\/10.1155\/2014\/768136.","journal-title":"Int J Biomater"},{"key":"1682_CR21","doi-asserted-by":"publisher","first-page":"6880","DOI":"10.1128\/AAC.01064-16","volume":"60","author":"BL Price","year":"2016","unstructured":"Price BL, Lovering AM, Bowling FL, Dobson CB. Development of a novel collagen wound model to simulate the activity and distribution of antimicrobials in soft tissue during diabetic foot infection. Antimicrob Agents Chemother. 2016;60:6880\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"1682_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2017.02591","volume":"8","author":"A Pompilio","year":"2017","unstructured":"Pompilio A, Galardi G, Verginelli F, Muzzi M, Di Giulio A, Di Bonaventura G. Myroides odoratimimus Forms Structurally Complex and Inherently Antibiotic-Resistant Biofilm in a Wound-Like in vitro Model. Front Microbiol. 2017;8:1\u201314. https:\/\/doi.org\/10.3389\/fmicb.2017.02591.","journal-title":"Front Microbiol"},{"key":"1682_CR23","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1111\/j.1365-2672.2009.04398.x","volume":"107","author":"RMS Thorn","year":"2009","unstructured":"Thorn RMS, Greenman J. A novel in vitro flat-bed perfusion biofilm model for determining the potential antimicrobial efficacy of topical wound treatments. J Appl Microbiol. 2009;107:2070\u20139. https:\/\/doi.org\/10.1111\/j.1365-2672.2009.04398.x.","journal-title":"J Appl Microbiol"},{"key":"1682_CR24","doi-asserted-by":"publisher","first-page":"502","DOI":"10.12968\/jowc.2008.17.11.31479","volume":"17","author":"DD Rhoads","year":"2008","unstructured":"Rhoads DD, Wolcott RD, Percival SL. Biofilms in wounds: management strategies. J Wound Care. 2008;17:502\u20138. https:\/\/doi.org\/10.12968\/jowc.2008.17.11.31479.","journal-title":"J Wound Care"},{"key":"1682_CR25","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1097\/01.BCR.0000112331.72232.1B","volume":"25","author":"PG Bowler","year":"2004","unstructured":"Bowler PG, Jones SA, Walker M, Parsons D. Microbicidal properties of a silver-containing Hydrofiber dressing against a variety of burn wound pathogens. J Burn Care Rehabil. 2004;25:192\u20136. https:\/\/doi.org\/10.1097\/01.BCR.0000112331.72232.1B.","journal-title":"J Burn Care Rehabil"},{"key":"1682_CR26","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ijpharm.2013.12.037","volume":"462","author":"J Said","year":"2014","unstructured":"Said J, Dodoo CC, Walker M, Parsons D, Stapleton P, Beezer AE, et al. An in vitro test of the efficacy of silver-containing wound dressings against Staphylococcus aureus and Pseudomonas aeruginosa in simulated wound fluid. Int J Pharm. 2014;462:123\u20138. https:\/\/doi.org\/10.1016\/j.ijpharm.2013.12.037.","journal-title":"Int J Pharm"},{"key":"1682_CR27","doi-asserted-by":"publisher","first-page":"274","DOI":"10.12968\/jowc.2014.23.5.274","volume":"23","author":"M Alrawi","year":"2014","unstructured":"Alrawi M, Crowley TP, Pape SA. Bacterial colonisation of the burn wound: a UK experience. J Wound Care. 2014;23:274\u20137. https:\/\/doi.org\/10.12968\/jowc.2014.23.5.274.","journal-title":"J Wound Care"},{"key":"1682_CR28","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1089\/sur.2009.024","volume":"10","author":"LK Branski","year":"2009","unstructured":"Branski LK, Al-Mousawi A, Rivero H, Jeschke MG, Sanford AP, Herndon DN. Emerging infections in burns. Surg Infect. 2009;10:389\u201397. https:\/\/doi.org\/10.1089\/sur.2009.024.","journal-title":"Surg Infect"},{"key":"1682_CR29","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/jac\/dkh536","volume":"55","author":"L Alou","year":"2005","unstructured":"Alou L, Aguilar L, Sevillano D, Gim\u00e9nez M-J, Echeverr\u00eda O, G\u00f3mez-Lus M-L, et al. Is there a pharmacodynamic need for the use of continuous versus intermittent infusion with ceftazidime against Pseudomonas aeruginosa? An in vitro pharmacodynamic model. J Antimicrob Chemother. 2005;55:209\u201313. https:\/\/doi.org\/10.1093\/jac\/dkh536.","journal-title":"J Antimicrob Chemother"},{"key":"1682_CR30","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1097\/FTD.0b013e3181e60ca6","volume":"32","author":"G Aubert","year":"2010","unstructured":"Aubert G, Carricajo A, Coudrot M, Guyomarc\u02bch S, Auboyer C, Zeni F. Prospective determination of serum Ceftazidime concentrations in intensive care units. Ther Drug Monit. 2010;32:517\u20139. https:\/\/doi.org\/10.1097\/FTD.0b013e3181e60ca6.","journal-title":"Ther Drug Monit"},{"issue":"2","key":"1682_CR31","doi-asserted-by":"publisher","first-page":"027102","DOI":"10.1088\/1752-7155\/9\/2\/027102","volume":"9","author":"Anne H Neerincx","year":"2015","unstructured":"Neerincx AH, Mandon J, van Ingen J, Arslanov DD, Mouton JW, Harren FJM, et al. Real-time monitoring of hydrogen cyanide (HCN) and ammonia (NH 3) emitted by Pseudomonas aeruginosa. J Breath Res 2015;9:027102. doi:https:\/\/doi.org\/10.1088\/1752-7155\/9\/2\/027102.","journal-title":"Journal of Breath Research"},{"key":"1682_CR32","doi-asserted-by":"publisher","first-page":"026010","DOI":"10.1088\/1752-7155\/7\/2\/026010","volume":"7","author":"FJ Gilchrist","year":"2013","unstructured":"Gilchrist FJ, Bright-Thomas RJ, Jones AM, Smith D, \u0160pan\u011bl P, Webb AK, et al. Hydrogen cyanide concentrations in the breath of adult cystic fibrosis patients with and without Pseudomonas aeruginosa infection. J Breath Res. 2013;7:026010. https:\/\/doi.org\/10.1088\/1752-7155\/7\/2\/026010.","journal-title":"J Breath Res"},{"key":"1682_CR33","doi-asserted-by":"publisher","DOI":"10.1088\/1752-7155\/7\/4\/044001","volume":"7","author":"D Smith","year":"2013","unstructured":"Smith D, \u0160pan\u011bl P, Gilchrist FJ, Lenney W. Hydrogen cyanide, a volatile biomarker of Pseudomonas aeruginosa infection. J Breath Res. 2013;7:044001. https:\/\/doi.org\/10.1088\/1752-7155\/7\/4\/044001.","journal-title":"J Breath Res"},{"key":"1682_CR34","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s002039900127","volume":"173","author":"C Blumer","year":"2000","unstructured":"Blumer C, Haas D. Mechanism, regulation, and ecological role of bacterial cyanide biosynthesis. Arch Microbiol. 2000;173:170\u20137. https:\/\/doi.org\/10.1007\/s002039900127.","journal-title":"Arch Microbiol"},{"key":"1682_CR35","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1039\/b905627k","volume":"134","author":"AD Spooner","year":"2009","unstructured":"Spooner AD, Bessant C, Turner C, Knobloch H, Chambers M. Evaluation of a combination of SIFT-MS and multivariate data analysis for the diagnosis of Mycobacterium bovis in wild badgers. Analyst. 2009;134:1922. https:\/\/doi.org\/10.1039\/b905627k.","journal-title":"Analyst"},{"key":"1682_CR36","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.mimet.2011.06.012","volume":"87","author":"MK Storer","year":"2011","unstructured":"Storer MK, Hibbard-Melles K, Davis B, Scotter J. Detection of volatile compounds produced by microbial growth in urine by selected ion flow tube mass spectrometry (SIFT-MS). J Microbiol Methods. 2011;87:111\u20133. https:\/\/doi.org\/10.1016\/j.mimet.2011.06.012.","journal-title":"J Microbiol Methods"},{"key":"1682_CR37","doi-asserted-by":"publisher","DOI":"10.1088\/1752-7155\/7\/1\/017105","volume":"7","author":"J Dummer","year":"2013","unstructured":"Dummer J, Storer M, Sturney S, Scott-Thomas A, Chambers S, Swanney M, et al. Quantification of hydrogen cyanide (HCN) in breath using selected ion flow tube mass spectrometry\u2014HCN is not a biomarker of Pseudomonas in chronic suppurative lung disease. J Breath Res. 2013;7:017105. https:\/\/doi.org\/10.1088\/1752-7155\/7\/1\/017105.","journal-title":"J Breath Res"},{"key":"1682_CR38","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/jam.13473","volume":"123","author":"EA Slade","year":"2017","unstructured":"Slade EA, Thorn RMS, Lovering AM, Young A, Reynolds DM. In vitro discrimination of wound-associated bacteria by volatile compound profiling using selected ion flow tube-mass spectrometry. J Appl Microbiol. 2017;123:233\u201345. https:\/\/doi.org\/10.1111\/jam.13473.","journal-title":"J Appl Microbiol"},{"key":"1682_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0188879","volume":"12","author":"JM Lewis","year":"2017","unstructured":"Lewis JM, Savage RS, Beeching NJ, Beadsworth MBJ, Feasey N, Covington JA. Identifying volatile metabolite signatures for the diagnosis of bacterial respiratory tract infection using electronic nose technology: a pilot study. PLoS One. 2017;12:e0188879. https:\/\/doi.org\/10.1371\/journal.pone.0188879.","journal-title":"PLoS One"},{"key":"1682_CR40","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/ffj.3151","volume":"28","author":"J Greenman","year":"2013","unstructured":"Greenman J, Saad S, Hewett K, Thorn RMS, Reynolds DM. Review: in vitro biofilm models for studying oral malodour. Flavour Fragr J. 2013;28:212\u201322. https:\/\/doi.org\/10.1002\/ffj.3151.","journal-title":"Flavour Fragr J"},{"key":"1682_CR41","doi-asserted-by":"publisher","first-page":"9431","DOI":"10.1038\/s41598-018-27504-z","volume":"8","author":"M Ashrafi","year":"2018","unstructured":"Ashrafi M, Novak-Frazer L, Bates M, Baguneid M, Alonso-Rasgado T, Xia G, et al. Validation of biofilm formation on human skin wound models and demonstration of clinically translatable bacteria-specific volatile signatures. Sci Rep. 2018;8:9431. https:\/\/doi.org\/10.1038\/s41598-018-27504-z.","journal-title":"Sci Rep"},{"key":"1682_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0027842","volume":"6","author":"AM Luj\u00e1n","year":"2011","unstructured":"Luj\u00e1n AM, Maci\u00e1 MD, Yang L, Molin S, Oliver A, Smania AM. Evolution and adaptation in Pseudomonas aeruginosa biofilms driven by mismatch repair system-deficient Mutators. PLoS One. 2011;6:e27842. https:\/\/doi.org\/10.1371\/journal.pone.0027842.","journal-title":"PLoS One"},{"key":"1682_CR43","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1046\/j.1365-2958.2003.03677.x","volume":"50","author":"M Klausen","year":"2003","unstructured":"Klausen M, Aaes-J\u00f8rgensen A, Molin S, Tolker-Nielsen T. Involvement of bacterial migration in the development of complex multicellular structures in Pseudomonas aeruginosa biofilms. Mol Microbiol. 2003;50:61\u20138. https:\/\/doi.org\/10.1046\/j.1365-2958.2003.03677.x.","journal-title":"Mol Microbiol"},{"key":"1682_CR44","doi-asserted-by":"publisher","first-page":"5238","DOI":"10.1128\/AEM.00637-11","volume":"77","author":"A Ghafoor","year":"2011","unstructured":"Ghafoor A, Hay ID, Rehm BHA. Role of exopolysaccharides in Pseudomonas aeruginosa biofilm formation and architecture. Appl Environ Microbiol. 2011;77:5238\u201346. https:\/\/doi.org\/10.1128\/AEM.00637-11.","journal-title":"Appl Environ Microbiol"},{"key":"1682_CR45","unstructured":"British Standards Institution. BS EN ISO 20776-1: Clinical laboratory testing and in vitro diagnostic test systems - Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices. 2006. https:\/\/www.standardsuk.com\/products\/BS-EN-ISO-20776-1-2006."},{"key":"1682_CR46","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 8.1. 2018. http:\/\/www.eucast.org."},{"key":"1682_CR47","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1093\/jac\/49.1.121","volume":"49","author":"SLCE Buijk","year":"2002","unstructured":"Buijk SLCE, Gyssens IC, Mouton JW, Van Vliet A, Verbrugh HA, Bruining HA. Pharmacokinetics of ceftazidime in serum and peritoneal exudate during continuous versus intermittent administration to patients with severe intra-abdominal infections. J Antimicrob Chemother. 2002;49:121\u20138 http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11751775.","journal-title":"J Antimicrob Chemother"},{"key":"1682_CR48","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1128\/CMR.19.2.403-434.2006","volume":"19","author":"D Church","year":"2006","unstructured":"Church D, Elsayed S, Reid O, Winston B, Lindsay R. Burn wound infections. Clin Microbiol Rev. 2006;19:403\u201334. https:\/\/doi.org\/10.1128\/CMR.19.2.403-434.2006.","journal-title":"Clin Microbiol Rev"},{"key":"1682_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF00562732","volume":"259","author":"WN Meigel","year":"1977","unstructured":"Meigel WN, Gay S, Weber L. Dermal architecture and collagen type distribution. Arch Dermatological Res. 1977;259:1\u201310. https:\/\/doi.org\/10.1007\/BF00562732.","journal-title":"Arch Dermatological Res"},{"key":"1682_CR50","first-page":"487","volume":"19","author":"J Vuolo","year":"2004","unstructured":"Vuolo J. Current options for managing the problem of excess wound exudate. Prof Nurse. 2004;19:487\u201391.","journal-title":"Prof Nurse"},{"key":"1682_CR51","doi-asserted-by":"publisher","first-page":"275","DOI":"10.12968\/jowc.2002.11.7.26414","volume":"11","author":"KF Cutting","year":"2002","unstructured":"Cutting KF, White RJ. Maceration of the skin and wound bed 1: its nature and causes. J Wound Care. 2002;11:275\u20138. https:\/\/doi.org\/10.12968\/jowc.2002.11.7.26414.","journal-title":"J Wound Care"},{"key":"1682_CR52","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1046\/j.1524-475X.1996.40211.x","volume":"4","author":"NJ Trengove","year":"1996","unstructured":"Trengove NJ, Langton SR, Stacey MC. Biochemical analysis of wound fluid from nonhealing and healing chronic leg ulcers. Wound Repair Regen. 1996;4:234\u20139. https:\/\/doi.org\/10.1046\/j.1524-475X.1996.40211.x.","journal-title":"Wound Repair Regen"},{"key":"1682_CR53","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1128\/CMR.14.2.244-269.2001","volume":"14","author":"PG Bowler","year":"2001","unstructured":"Bowler PG, Duerden BI, Armstrong DG. Wound microbiology and associated approaches to wound management. Clin Microbiol Rev. 2001;14:244\u201369. https:\/\/doi.org\/10.1128\/CMR.14.2.244-269.2001.","journal-title":"Clin Microbiol Rev"},{"key":"1682_CR54","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1097\/01.BCR.0000095507.45481.76","volume":"24","author":"T Sj\u00f6berg","year":"2003","unstructured":"Sj\u00f6berg T, Mzezewa S, J\u00f6nsson K, Robertson V, Salemark L. Comparison of surface swab cultures and quantitative tissue biopsy cultures to predict Sepsis in burn patients: a prospective study. J Burn Care Rehabil. 2003;24:365\u201370. https:\/\/doi.org\/10.1097\/01.BCR.0000095507.45481.76.","journal-title":"J Burn Care Rehabil"},{"key":"1682_CR55","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/J.BURNS.2006.08.015","volume":"33","author":"SK Uppal","year":"2007","unstructured":"Uppal SK, Ram S, Kwatra B, Garg S, Gupta R. Comparative evaluation of surface swab and quantitative full thickness wound biopsy culture in burn patients. Burns. 2007;33:460\u20133. https:\/\/doi.org\/10.1016\/J.BURNS.2006.08.015.","journal-title":"Burns"},{"key":"1682_CR56","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/00005373-197602000-00002","volume":"16","author":"NS Levine","year":"1976","unstructured":"Levine NS, Lindberg RB, Mason AD, Pruitt BA. The quantitative swab culture and smear: a quick, simple method for determining the number of viable aerobic bacteria on open wounds. J Trauma Inj Infect Crit Care. 1976;16:89\u201394. https:\/\/doi.org\/10.1097\/00005373-197602000-00002.","journal-title":"J Trauma Inj Infect Crit Care"},{"key":"1682_CR57","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1128\/JCM.37.6.1771-1776.1999","volume":"37","author":"H Ceri","year":"1999","unstructured":"Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A. The Calgary biofilm device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol. 1999;37:1771\u20136 http:\/\/jcm.asm.org\/content\/37\/6\/1771.abstract.","journal-title":"J Clin Microbiol"},{"key":"1682_CR58","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1099\/00222615-17-2-159","volume":"17","author":"TSJ Elliott","year":"1984","unstructured":"Elliott TSJ, Greenwood D. The morphological response of Pseudomonas aeruginosa to azthreonam, cefoperazone, ceftazidime and N-formimidoyl thienamycin. J Med Microbiol. 1984;17:159\u201369. https:\/\/doi.org\/10.1099\/00222615-17-2-159.","journal-title":"J Med Microbiol"},{"key":"1682_CR59","doi-asserted-by":"publisher","first-page":"e01651","DOI":"10.1128\/AAC.01651-16","volume":"61","author":"W Chen","year":"2017","unstructured":"Chen W, Zhang Y-M, Davies C. Penicillin-binding protein 3 is essential for growth of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2017;61:e01651\u201316. https:\/\/doi.org\/10.1128\/AAC.01651-16.","journal-title":"Antimicrob Agents Chemother"},{"key":"1682_CR60","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.molcel.2012.09.016","volume":"48","author":"Z Yao","year":"2012","unstructured":"Yao Z, Kahne D, Kishony R. Distinct single-cell morphological dynamics under beta-lactam antibiotics. Mol Cell. 2012;48:705\u201312. https:\/\/doi.org\/10.1016\/j.molcel.2012.09.016.","journal-title":"Mol Cell"},{"key":"1682_CR61","first-page":"274","volume":"27","author":"V Dini","year":"2015","unstructured":"Dini V, Salvo P, Janowska A, Di Francesco F, Barbini A, Romanelli M. Correlation between wound temperature obtained with an infrared camera and clinical wound bed score in venous leg ulcers. Wounds. 2015;27:274\u20138 https:\/\/www.woundsresearch.com\/article\/correlation-between-wound-temperature-obtained-infrared-camera-and-clinical-wound-bed-score.","journal-title":"Wounds"},{"key":"1682_CR62","first-page":"145","volume":"8","author":"S Thomas","year":"1996","unstructured":"Thomas S, Fear M, Humphreys J, Disley L, Waring M. The effect of dressings on the production of exudate from venous leg ulcers. Wounds. 1996;8:145\u201350.","journal-title":"Wounds."},{"key":"1682_CR63","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9:676\u201382. https:\/\/doi.org\/10.1038\/nmeth.2019.","journal-title":"Nat Methods"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-019-1682-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12866-019-1682-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-019-1682-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,29]],"date-time":"2020-12-29T00:28:46Z","timestamp":1609201726000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/s12866-019-1682-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1682"],"URL":"https:\/\/doi.org\/10.1186\/s12866-019-1682-5","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"20 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"310"}}